Form 4: Mersana Therapeutics SVP, Chief Sci.&Tech. Officer Timothy B Lowinger Reports Stock Transactions
SEC Form 4
Timothy B Lowinger, SVP, Chief Sci.&Tech. Officer of Mersana Therapeutics, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On October 1, 2024, Timothy B Lowinger vested 50,000 restricted stock units (RSUs) of Mersana Therapeutics, each representing one share of common stock.
- Following the vesting, Lowinger sold 8,089 shares on October 2, 2024, at an average price of $2 per share and 5,598 shares on October 3, 2024, at an average price of $1.96 per share.
- These sales were executed to cover tax withholding obligations related to the vesting of the RSUs, pursuant to a pre-arranged Rule 10b5-1 trading plan.
- After these transactions, Lowinger directly owns 235,642 shares of Mersana Therapeutics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions are related to standard vesting and tax obligations, executed under a pre-arranged plan.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.
Key Dates
| Date | Description |
|---|---|
| May 10, 2023 | Reporting Person adopted a Rule 10b5-1 trading plan |
| September 5, 2023 | Date of RSU award to Reporting Person |
| October 1, 2024 | Vesting date of 50,000 restricted stock units. |
| October 2, 2024 | Sale of 8,089 shares of common stock at an average price of $2. |
| October 3, 2024 | Sale of 5,598 shares of common stock at an average price of $1.96. |
| October 7, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.